广州白云山医药集团股份有限公司于2026年3月3日发布2026年2月股份变动月报表。公告显示，报告期内公司H股（股票代码：00874）与A股（股票代码：600332）已发行股份总数均保持不变，未发生新增发行、购回或注销等变动。
根据公告，截至2026年2月末，公司H股已发行股份数为219,900,000股，A股已发行股份数为1,405,890,949股，总股本为1,625,790,949股，与上月底持平。公告同时确认，公司在本月无任何股权激励与期权计划变动，也不存在库藏股或可转换债券发行等活动。
公司强调已严格遵守香港联交所《上市规则》及相关法律规定，并确认所有上市事项均获董事会正式授权。该月报由公司秘书黄雪贞签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.